PATENT CLAIM ANALYSIS

Application Number: 15756824
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
Provided are a monoclonal antibody specific for BQ323636.1, and its use for prediction of tamoxifen resistance in breast cancer patients.

Claim (Index 11):
A kit comprising the antibody or antibody fragment of  claim 1 , the kit optionally further comprising a labeled secondary antibody that specifically recognizes the antibody or antibody fragment of  claim 1 .

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14429657', '10591199', '13568145', '13177523', '12825057']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7070727688244385
- 35 USC 102 Novelty (BERT): 0.5051354732766486
- Combined Prediction Score: 0.6868790392696595
- Mean Citation Score: 266.799774
- Max Citation Score: 274.01337
- Similarity Product: 198.6925280468488

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test